ISTH SSC Delphi consensus guidance on unfractionated heparin monitoring prefers anti-Xa assays over aPTT, suggests a target anti-Xa of 0.30–0.70 U/mL for most indications, and recommends weight-based nomograms and 3.2% citrate tubes, with no routine CTAD tubes.
Guideline
Gouin-Thibault et al. How to monitor and manage unfractionated heparin in practice (Part 1)? Guidance from the SSC of the ISTH